The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Iron and dopamine: a toxic couple
Abstract
Iron accumulation is a cardinal feature of degenerating regions in the Parkinson's disease brain. As a potent pro-oxidant, redox-active iron may be a key player in upstream mechanisms that precipitate cell death in this disorder. Although an elevation in brain iron levels is a normal feature of ageing, the increase is greater in Parkinson's disease; on the other hand, the effects of the disease are most marked in the nigrostriatal dopaminergic system. In this Update, we explain that neurodegeneration in the affected regions may result from the potent redox couple formed by iron and dopamine itself, and discuss the clinical implications of this molecular trait in this dynamic and rapidly moving area of Parkinson's disease research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301
Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., & Bartus, R. T. (2013) · Brain · doi:10.1093/brain/awt192 · Cited by 1,286
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein
Lotharius, J., & Brundin, P. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn983 · Cited by 1,283
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
The role of iron regulatory proteins in mammalian iron homeostasis and disease
Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055
DEXTER, D. T., CARAYON, A., JAVOY-AGID, F., AGID, Y., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P., & MARSDEN, C. D. (1991) · Brain · doi:10.1093/brain/114.4.1953 · Cited by 1,043
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,029
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
Devos, D., Moreau, C., Devedjian, J. C., Kluza, J., Petrault, M., Laloux, C., Jonneaux, A., Ryckewaert, G., Garçon, G., Rouaix, N., et al. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5593 · Cited by 619
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., Wong, B. X. W., Adlard, P. A., Cherny, R. A., Lam, L. Q., et al. (2012) · Nature Medicine · doi:10.1038/nm.2613 · Cited by 594
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
LaVaute, T., Smith, S., Cooperman, S., Iwai, K., Land, W., Meyron-Holtz, E., Drake, S. K., Miller, G., Abu-Asab, M., Tsokos, M., et al. (2001) · Nature Genetics · doi:10.1038/84859 · Cited by 509
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V., & Adalsteinsson, E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.077 · Cited by 499
Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.680090 · Cited by 498
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 474
The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466
Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases
Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., & Youdim, M. B. H. (1990) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02252926 · Cited by 445
A delicate balance: Iron metabolism and diseases of the brain
Hare, D., Ayton, S., Bush, A., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 443
Self-citationIron trafficking inside the brain
Moos, T., Nielsen, T. R., Skjørringe, T., & Morgan, E. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04976.x · Cited by 420
Becker, G., Seufert, J., Bogdahn, U., Reichmann, H., & Reiners, K. (1995) · Neurology · doi:10.1212/wnl.45.1.182 · Cited by 397
Mechanism of 6-hydroxydopamine neurotoxicity
Glinka, Y., Gassen, M., & Youdim, M. B. H. (1997) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6842-4_7 · Cited by 380
Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla
Ordidge, R. J., Gorell, J. M., Deniau, J. C., Knight, R. A., & Helpern, J. A. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320309 · Cited by 323
Unity in the Biochemistry of the Iron-Storage Proteins Ferritin and Bacterioferritin
Honarmand Ebrahimi, K., Hagedoorn, P.-L., & Hagen, W. R. (2015) · Chemical Reviews · doi:10.1021/cr5004908 · Cited by 297
Selenium, selenoproteins and neurodegenerative diseases
Cardoso, B. R., Roberts, B. R., Bush, A. I., & Hare, D. J. (2015) · Metallomics · doi:10.1039/c5mt00075k · Cited by 295
Self-citationCeruloplasmin dysfunction and therapeutic potential for Parkinson disease
Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264
Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., Colombo, L., Manzoni, C., Salmona, M., Caccia, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06228.x · Cited by 260
Barbosa, J. H. O., Santos, A. C., Tumas, V., Liu, M., Zheng, W., Haacke, E. M., & Salmon, C. E. G. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.02.021 · Cited by 258
Copper pathology in vulnerable brain regions in Parkinson's disease
Davies, K. M., Bohic, S., Carmona, A., Ortega, R., Cottam, V., Hare, D. J., Finberg, J. P. M., Reyes, S., Halliday, G. M., Mercer, J. F. B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.034 · Cited by 244
Self-citationFerritin, transferrin, and iron in selected regions of the adult and aged rat brain
Benkovic, S. A., & Connor, J. R. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903380108 · Cited by 238
Gaenslen, A., Unmuth, B., Godau, J., Liepelt, I., Di Santo, A., Schweitzer, K. J., Gasser, T., Machulla, H.-J., Reimold, M., Marek, K., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70067-x · Cited by 234
Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems
Brichta, L., Greengard, P., & Flajolet, M. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.06.003 · Cited by 223
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M. I., Griffiths, F. M., Shepherd, C. E., & Double, K. L. (2005) · Brain · doi:10.1093/brain/awh584 · Cited by 219
Self-citationZecca, L., Berg, D., Arzberger, T., Ruprecht, P., Rausch, W. D., Musicco, M., Tampellini, D., Riederer, P., Gerlach, M., & Becker, G. (2005) · Movement Disorders · doi:10.1002/mds.20550 · Cited by 214
High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease
Lotfipour, A. K., Wharton, S., Schwarz, S. T., Gontu, V., Schäfer, A., Peters, A. M., Bowtell, R. W., Auer, D. P., Gowland, P. A., & Bajaj, N. P. S. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22752 · Cited by 208
Imaging metals in biology: balancing sensitivity, selectivity and spatial resolution
Hare, D. J., New, E. J., de Jonge, M. D., & McColl, G. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00055f · Cited by 201
Self-citationMastroberardino, P. G., Hoffman, E. K., Horowitz, M. P., Betarbet, R., Taylor, G., Cheng, D., Na, H. M., Gutekunst, C.-A., Gearing, M., Trojanowski, J. Q., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.009 · Cited by 195
Lipopolysaccharide Animal Models for Parkinson's Disease
Liu, M., & Bing, G. (2011) · Parkinson's Disease · doi:10.4061/2011/327089 · Cited by 190
Iron-binding characteristics of neuromelanin of the human substantia nigra
Double, K. L., Gerlach, M., Schünemann, V., Trautwein, A. X., Zecca, L., Gallorini, M., Youdim, M. B. H., Riederer, P., & Ben-Shachar, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00293-4 · Cited by 181
Self-citationFriedlich, A. L., Tanzi, R. E., & Rogers, J. T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001937 · Cited by 181
The comparative biology of neuromelanin and lipofuscin in the human brain
Double, K. L., Dedov, V. N., Fedorow, H., Kettle, E., Halliday, G. M., Garner, B., & Brunk, U. T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7581-9 · Cited by 179
Self-citationIsoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179
Raha, A. A., Vaishnav, R. A., Friedland, R. P., Bomford, A., & Raha-Chowdhury, R. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-55 · Cited by 177
Preclinical Biomarkers of Parkinson Disease
Wu, Y., Le, W., & Jankovic, J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.321 · Cited by 169
Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons
Saha, A. R., Hill, J., Utton, M. A., Asuni, A. A., Ackerley, S., Grierson, A. J., Miller, C. C., Davies, A. M., Buchman, V. L., Anderton, B. H., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.00967 · Cited by 169
Wong, B. X. W., Tsatsanis, A., Lim, L. Q., Adlard, P. A., Bush, A. I., & Duce, J. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114174 · Cited by 167
Skjørringe, T., Burkhart, A., Johnsen, K. B., & Moos, T. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00019 · Cited by 166
Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
Bartus, R. T., Weinberg, M. S., & Samulski, R. J. (2014) · Molecular Therapy · doi:10.1038/mt.2013.281 · Cited by 164
Neuropathology of α‐synuclein propagation and braak hypothesis
McCann, H., Cartwright, H., & Halliday, G. M. (2015) · Movement Disorders · doi:10.1002/mds.26421 · Cited by 157
Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
Napolitano, A., Manini, P., & d’Ischia, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795496863 · Cited by 153
In Vitro Studies of Ferritin Iron Release and Neurotoxicity
Double, K. L., Maywald, M., Schmittel, M., Riederer, P. F., & Gerlach, M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70062492.x · Cited by 152
Self-citationAyton, S., Lei, P., Hare, D. J., Duce, J. A., George, J. L., Adlard, P. A., McLean, C., Rogers, J. T., Cherny, R. A., Finkelstein, D. I., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3439-14.2015 · Cited by 140
Self-citationSelective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?
Double, K. L., Reyes, S., Werry, E. L., & Halliday, G. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.001 · Cited by 137
Self-citationWhy are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
Hirsch, É. C. (1992) · Annals of Neurology · doi:10.1002/ana.410320715 · Cited by 136
Pezzella, A., d’Ischia, M., Napolitano, A., Misuraca, G., & Prota, G. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970099t · Cited by 133
Hoogendijk, W. J. G., Pool, C. W., Troost, D., van Zwieten, E. J., & Swaab, D. F. (1995) · Brain · doi:10.1093/brain/118.1.131 · Cited by 132
Divalent metal transporter 1 (DMT1) regulation by Ndfip1 prevents metal toxicity in human neurons
Howitt, J. A., Putz, U., Lackovic, J., Doan, A., Dorstyn, L., Cheng, H. B., Yang, B., Chan‐Ling, T., Silke, J., Kumar, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904880106 · Cited by 128
6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation
Monteiro, H. P., & Winterbourn, C. C. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90512-1 · Cited by 125
Hare, D. J., Lei, P., Ayton, S., Roberts, B. R., Grimm, R., George, J. L., Bishop, D., Beavis, A. D., Donovan, S. J., McColl, G., et al. (2014) · Chemical Science · doi:10.1039/c3sc53461h · Cited by 125
Self-citationDirect in vivo imaging of ferrous iron dyshomeostasis in ageing Caenorhabditis elegans
James, S., Roberts, B. R., Hare, D. J., de Jonge, M. D., Birchall, I. E., Jenkins, N. L., Cherny, R. A., Bush, A. I., & McColl, G. (2015) · Chemical Science · doi:10.1039/c5sc00233h · Cited by 122
Self-citationHare, D. J., Reedy, B. J., Grimm, R., Wilkins, S., Volitakis, I., George, J. L., Cherny, R. A., Bush, A. I., Finkelstein, D. I., & Doble, P. (2008) · Metallomics · doi:10.1039/b816188g · Cited by 120
Self-citationCeruloplasmin-ferroportin system of iron traffic in vertebrates
Musci, G., Polticelli, F., & di Patti, M. C. B. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.204 · Cited by 120
Lhermitte, J., Kraus, W. M., & McAlpine, D. (1924) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-5.19.195 · Cited by 119
Wang, Q. L., Du, F., Qian, Z., Ge, X., Zhu, L., Yung, W., Yang, L., & Ke, Y. (2008) · Endocrinology · doi:10.1210/en.2007-1626 · Cited by 118
Bohic, S., Murphy, K., Paulus, W., Cloetens, P., Salome-Pateyron, M., Susini, J., & Double, K. L. (2008) · Analytical Chemistry · doi:10.1021/ac801817k · Cited by 117
Self-citationFaucheux, B. A., Martin, M., Beaumont, C., Hunot, S., Hauw, J., Agid, Y., & Hirsch, E. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01118.x · Cited by 116
Xu, Q., Kanthasamy, A. G., & Reddy, M. B. (2011) · Parkinson s Disease · doi:10.4061/2011/431068 · Cited by 113
Detection of ubiquitinated huntingtin species in intracellular aggregates
Juenemann, K., Wiemhoefer, A., & Reits, E. A. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00001 · Cited by 113
Muñoz, V. F. L., & Paricio, N. (2011) · Parkinson s Disease · doi:10.4061/2011/520640 · Cited by 111
Licker, V., Turck, N., Kövari, E., Burkhardt, K., Côte, M., Surini, M., Lobrinus, J. A., Sanchez, J., & Burkhard, P. R. (2014) · PROTEOMICS · doi:10.1002/pmic.201300342 · Cited by 108
Is early-life iron exposure critical in neurodegeneration?
Hare, D. J., Arora, M., Jenkins, N. L., Finkelstein, D. I., Doble, P., & Bush, A. I. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.100 · Cited by 108
Self-citationMcCarthy, R. C., & Kosman, D. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00031 · Cited by 106
Frequency-specific modulation of population-level frequency tuning in human auditory cortex
Okamoto, H., Stracke, H., Zwitserlood, P., Roberts, L. E., & Pantev, C. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-1 · Cited by 106
McCarthy, R. C., & Kosman, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089003 · Cited by 105
Thomsen, M. S., Andersen, M. V., Christoffersen, P., Jensen, M. D., Lichota, J., & Moos, T. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.013 · Cited by 103
Ben‐Shachar, D., Eshel, G., Riederer, P. F., & Youdim, M. B. H. (1992) · Annals of Neurology · doi:10.1002/ana.410320718 · Cited by 95
Generation of the Neurotoxin 6-Hydroxydopamine by Peroxidase/H2O2 Oxidation of Dopamine
Napolitano, A., Crescenzi, O., Pezzella, A., & Prota, G. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00006a010 · Cited by 95
Expression of iron-related genes in human brain and brain tumors
Hänninen, M., Haapasalo, J. A., Haapasalo, H. K., Fleming, R. E., Britton, R. S., Bacon, B. R., & Parkkila, S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-36 · Cited by 92
Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
Bisaglia, M., Filograna, R., Beltramini, M., & Bubacco, L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.009 · Cited by 88
Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrin
Rhodes, S. L., Buchanan, D. D., Ahmed, I., Taylor, K. D., Loriot, M., Sinsheimer, J. S., Bronstein, J. M., Elbaz, A., Mellick, G. D., Rotter, J. I., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.019 · Cited by 87
Hauser, D. N., Dukes, A. A., Mortimer, A. D., & Hastings, T. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.030 · Cited by 87
Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites
Hastings, T. G., & Zigmond, M. J. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_11 · Cited by 81
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, D. J., Adlard, P. A., Doble, P. A., & Finkelstein, D. I. (2013) · Metallomics · doi:10.1039/c2mt20164j · Cited by 78
Self-citationOrtega, R., Carmona, A., Roudeau, S., Perrin, L., Dučić, T., Carboni, E., Bohic, S., Cloetens, P., & Lingor, P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9146-x · Cited by 76
Moos, T., & Nielsen, T. R. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.08.003 · Cited by 72
Lv, Z., Jiang, H. F., Xu, H., Song, N., & Xie, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0434-3 · Cited by 71
Vekrellis, K., & Stefanis, L. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.674111 · Cited by 69
Expression and cellular localization of hepcidin mRNA and protein in normal rat brain
Raha‐Chowdhury, R., Raha, A. A., Forostyak, S., Zhao, J., Stott, S., & Bomford, A. B. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0161-7 · Cited by 69
Napolitano, A., Pezzella, A., & Prota, G. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990079p · Cited by 67
Risk factors and prodromal markers and the development of Parkinson’s disease
Lerche, S., Seppi, K., Behnke, S., Liepelt‐Scarfone, I., Godau, J., Mahlknecht, P., Gaenslen, A., Brockmann, K., Srulijes, K., Huber, H., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7171-0 · Cited by 59
Tools to study distinct metal pools in biology
New, E. J. (2012) · Dalton Transactions · doi:10.1039/c2dt31933k · Cited by 52
The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neurons
Chung, J. Y., Kim, H., & Kim, M. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0140-z · Cited by 48
Spencer, B. J., Valera, E., Rockenstein, E. M., Trejo, M., Adame, A., & Masliah, E. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0043-6 · Cited by 48
Zhou, Z., Lan, Y. H., Tan, E. K., & Lim, T. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.010 · Cited by 46
Ndfip1 attenuated 6-OHDA–induced iron accumulation via regulating the degradation of DMT1
Jia, W., Xu, H., Du, X., Jiang, H. F., & Xie, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.021 · Cited by 34
Howitt, J. A., Gysbers, A. M., Ayton, S., Carew‐Jones, F., Putz, U., Finkelstein, D. I., Halliday, G. M., & Tan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087119 · Cited by 33
Surówka, A. D., Wróbel, P., Adamek, D., Radwańska, E., & Szczerbowska‐Boruchowska, M. (2015) · Metallomics · doi:10.1039/c5mt00154d · Cited by 20
Zhang, L., Yagnik, G. B., Jiang, D., Shi, S., Chang, P., & Zhou, F. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.10.026 · Cited by 18
Sparse coding of natural communication signals in midbrain neurons
Vonderschen, K., & Chacron, M. J. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-s1-o3 · Cited by 18
Pathophysiology of Transcranial Sonography Signal Changes in the Human Substantia Nigra
Double, K. L., Todd, G., & Duma, S. R. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)90008-1 · Cited by 11
Self-citation
Cited by
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Self-citationYarjanli, Z., Ghaedi, K., Esmaeili, A., Rahgozar, S., & Zarrabi, A. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0369-9 · Cited by 296
Eid, R., Arab, N. T. T., & Greenwood, M. T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.12.002 · Cited by 288
Glutathione peroxidase 4: a new player in neurodegeneration?
Cardoso, B. R., Hare, D. J., Bush, A. I., & Roberts, B. R. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.196 · Cited by 281
Self-citationDopamine promotes cellular iron accumulation and oxidative stress responses in macrophages
Dichtl, S., Haschka, D., Nairz, M., Seifert, M., Volani, C., Lutz, O., & Weiss, G. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.001 · Cited by 76
Metadata
- Authors
- Hare, D. J., & Double, K. L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-08
- Volume
- 139
- Issue
- 4
- Pages
- 1026-1035
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2294172555
- Cited by
- 283
- References
- 109
- FWCI
- 19.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.